Zentalis Pharmaceuticals Stock Target Price and Analyst Consensus
| ZNTL Stock | USD 1.77 0.04 2.21% |
The current analyst and expert consensus on Zentalis Pharmaceuticals is Buy with 6 hold recommendations. The current projected Zentalis Pharmaceuticals target price consensus is 9.50 with 11 analyst opinions. One of the most common ways Zentalis Pharmaceuticals analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Zentalis Pharmaceuticals vendors, executives, and/or customers. Zentalis Pharmaceuticals recommendation module provides expert sentiment on the projected Zentalis Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 7.1552.
Lowest Forecast 8.65 | Highest Forecast 10.55 | Target Price 9.5 |
Zentalis |
It's important to approach Zentalis Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Zentalis Pharmaceuticals price targets
Zentalis Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Zentalis Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Zentalis Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Zentalis Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Zentalis Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Zentalis Pharmaceuticals is a key component of Zentalis Pharmaceuticals valuation and have some predictive power on the future returns of a Zentalis Pharmaceuticals.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Zentalis Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Macroaxis Picks Invested few shares | |
 | Corona Opportunity Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Driverless Cars Invested over 60 shares | |
 | Adviser Favorites Invested few shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Basic Utilities Invested over 90 shares | |
Check out Macroaxis Advice on Zentalis Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.